ArticleEuropean journal of nuclear medicine and molecular imaging2025

Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia.

Moritz B Bastian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.